285 related articles for article (PubMed ID: 6466260)
1. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
[TBL] [Abstract][Full Text] [Related]
2. Scopolamine alone or combined with ephedrine in seasickness: a double-blind, placebo-controlled study.
Laitinen LA; Tokola O; Gothoni G; Vapaatalo H
Aviat Space Environ Med; 1981 Jan; 52(1):6-10. PubMed ID: 7011299
[TBL] [Abstract][Full Text] [Related]
3. Chlorpheniramine and ephedrine in combination for motion sickness.
Buckey JC; Alvarenga DL; MacKenzie TA
J Vestib Res; 2007; 17(5-6):301-11. PubMed ID: 18626140
[TBL] [Abstract][Full Text] [Related]
4. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel A; Knepton J; Shaw J
Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the effectiveness of drugs for prevention of motion sickness].
Galle RR; Gusakova GA; Sabaev VV; Galle NN
Kosm Biol Aviakosm Med; 1988; 22(4):90-4. PubMed ID: 3066982
[No Abstract] [Full Text] [Related]
6. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
Attias J; Gordon C; Ribak J; Binah O; Rolnick A
Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
Pingree BJ; Pethybridge RJ
Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
[TBL] [Abstract][Full Text] [Related]
8. Scopolamine (hyoscine) for preventing and treating motion sickness.
Spinks A; Wasiak J
Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD002851. PubMed ID: 21678338
[TBL] [Abstract][Full Text] [Related]
9. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
Graybiel A; Cramer DB; Wood CD
Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for motion sickness: cardiovascular effects.
Sunahara FA; Farewell J; Mintz L; Johnson WH
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A270-6. PubMed ID: 3499896
[TBL] [Abstract][Full Text] [Related]
12. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
[TBL] [Abstract][Full Text] [Related]
13. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
Noy S; Shapira S; Zilbiger A; Ribak J
Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
[TBL] [Abstract][Full Text] [Related]
14. Effect of transdermally administered scopolamine in preventing motion sickness.
McCauley ME; Royal JW; Shaw JE; Schmitt LG
Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
[TBL] [Abstract][Full Text] [Related]
15. Scopolamine (hyoscine) for preventing and treating motion sickness.
Spinks AB; Wasiak J; Villanueva EV; Bernath V
Cochrane Database Syst Rev; 2007 Jul; (3):CD002851. PubMed ID: 17636710
[TBL] [Abstract][Full Text] [Related]
16. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
Shupak A; Gordon CR; Spitzer O; Mendelowitz N; Melamed Y
Pharmatherapeutica; 1989; 5(6):365-70. PubMed ID: 2594820
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
[TBL] [Abstract][Full Text] [Related]
18. Modafinil as a potential motion sickness countermeasure.
Hoyt RE; Lawson BD; McGee HA; Strompolis ML; McClellan MA
Aviat Space Environ Med; 2009 Aug; 80(8):709-15. PubMed ID: 19653573
[TBL] [Abstract][Full Text] [Related]
19. Treatment of motion sickness in parabolic flight with buccal scopolamine.
Norfleet WT; Degioanni JJ; Calkins DS; Reschke MF; Bungo MW; Kutyna FA; Homick JL
Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533
[TBL] [Abstract][Full Text] [Related]
20. Scopolamine for preventing and treating motion sickness.
Spinks AB; Wasiak J; Villanueva EV; Bernath V
Cochrane Database Syst Rev; 2004; (3):CD002851. PubMed ID: 15266468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
